Will abolishing NHS England lead to better care?
While removing NHS England will eliminate some bureaucratic overhead, it won’t solve the system’s deeper issues. Without substantial investment, meaningful workforce support, and a coherent
Senior moderator Leigh Hart explores the role of pharmaceutical companies in the Rare Disease Networks, what was planned and how it has worked out. Rare diseases are far from rare. An estimated 300 to 400 million people live with one, yet their needs are often invisible to health systems, researchers, and the medical sciences industry. […]
While removing NHS England will eliminate some bureaucratic overhead, it won’t solve the system’s deeper issues. Without substantial investment, meaningful workforce support, and a coherent
LDA Research has recently welcomed Julia Heck to our team as Senior Research Manager. Market research holds a special place in Julia’s heart as she
Erin Paterson shares her experience of being gene positive for the rare Huntington disease, and how she is on a mission to positively impact other
Our Research Consultant Andrew Grant advocates for awareness of the physical and mental issues patients face while their condition remains undiagnosed Getting a diagnosis when
LDA Research is supporting CureLONP1.com Aria’s Miracle research fund and her parent’s conviction that hope lies within the global medical and scientific community Aria’s parents need to
Senior research manager, Rachel Barnes, discusses the methods LDA Research takes to prevent fraudulent respondents when recruiting for patient research providing a genuine and high
